Packaging Coordinators, Inc. (PCI), a US-based supplier of pharmaceutical commercial packaging solutions and clinical trials services announces developments in its anti-counterfeiting initiatives for pharmaceutical packaging. The company’s new service offering is outlined in a new white paper, available to download via PCI anti-counterfeiting white paper; and details its identification solution, which uses a unique identification code on each pack, generated and applied by the packer.
The complexity of the European supply chain is one of the key factors driving the counterfeiting pandemic, the firm claims, with millions of medicine packs being moved around the EU annually. According to the firm, a stumbling block within the industry remains the lack of a unified, single-source pan-European or indeed global database, where scanned bar codes on drug packaging can be verified at point of dispense. The report reviews the current regulatory landscape worldwide and also looks at the traditional methods currently used to battle imitation drugs. The white paper debates the wider impacts of counterfeiting in the industry and the implications that this has within the industry. The firm’s product uses on-line application and verification of serialized Radio Frequency Identification tags and Two-Dimensional barcode technology, with data management and processing, allowing customers’ compliance with state, governmental and multinational packaging regulations, as well as specific industry and supply chain requirements. A 2D data matrix bar code is applied to the packet containing a unique serial number, with the lot number, expiry date, GTIN (supplied by client) and material code. The product verification process then compares the data held within the data matrix code with a secure product record on a database.
For more information on PCI and its services, email [email protected], call +44 (0) 1497 820829 or visit – www.pciservices.com
